Login to Your Account



Complix Gets $16M for Its Alphabody Scaffold Technology

By Cormac Sheridan
Staff Writer

Wednesday, July 3, 2013
Complix NV raised €12 million (US$15.6 million) in a Series B round to fund development of small-protein therapeutics based on its alphabody scaffold platform.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription